ATAI Life Sciences N.V.·4

Jun 4, 4:38 PM ET

Angermayer Christian 4

4 · ATAI Life Sciences N.V. · Filed Jun 4, 2025

Insider Transaction Report

Form 4
Period: 2025-06-02
Angermayer Christian
Director10% Owner
Transactions
  • Award

    Stock Option

    2025-06-02+131,698131,698 total
    Exercise: $2.49Exp: 2035-06-02Common Shares (131,698 underlying)
Footnotes (2)
  • [F1]On June 2, 2025, the Issuer granted stock options to the Reporting Person in further consideration of his continued service as a consultant and other valuable consideration.
  • [F2]The stock options shall vest as to 25% on June 2, 2026, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person entering into an amended consultancy agreement, the Reporting Person's continued service to the Issuer through each applicable vesting date and Apeiron Investment Group Ltd.'s compliance with the Voting Agreement dated as of June 2, 2025 by and among Beckley Psytech Limited, Atai Life Sciences N.V. and Apeiron Investment Group Ltd.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4